Polyrizon Quote - PLRZ

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.06

Bid

2.04

Ask

2.11

Volume

2,409

0.00 Day's Range 0.00

0.77 52 Week Range 4.80

Market Cap

8.329M

Previous Close

2.17

Open

Last Trade

2.05

Last Trade Time

03:34:52

Financial Volume

VWAP

Average Volume (3m)

4,011,535

Shares Outstanding

4,043,234

Dividend Yield

PE Ratio

-14.62

Earnings Per Share (EPS)

-0.15

Revenue

Net Profit

-600k

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from... Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.polyrizon-biotech.com

Headquarters

Ra'anana, Center, Isr

Founded

Polyrizon Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PLRZ. The last closing price for Polyrizon was US$2.17. Over the last year, Polyrizon shares have traded in a share price range of US$ 0.77 to US$ 4.80.

Polyrizon currently has 4,043,234 shares outstanding. The market capitalization of Polyrizon is US$8.77 million. Polyrizon has a price to earnings ratio (PE ratio) of -14.62.

Form F-1 - Registration statement for certain foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Raanana, Israel, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of...

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production...

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-0.961538461538	2.08	2.8	1.6	4624013	2.14744769	CS
4	1.09	112.371134021	0.97	4.8	0.92	9447621	3.01333407	CS
12	0.42	25.6097560976	1.64	4.8	0.77	4011535	2.92035961	CS
26	0.42	25.6097560976	1.64	4.8	0.77	4011535	2.92035961	CS
52	0.42	25.6097560976	1.64	4.8	0.77	4011535	2.92035961	CS
156	0.42	25.6097560976	1.64	4.8	0.77	4011535	2.92035961	CS
260	0.42	25.6097560976	1.64	4.8	0.77	4011535	2.92035961	CS

PLRZ - Frequently Asked Questions (FAQ)

What is the current Polyrizon share price?

The current share price of Polyrizon is US$ 2.06

How many Polyrizon shares are in issue?

Polyrizon has 4,043,234 shares in issue

What is the market cap of Polyrizon?

The market capitalisation of Polyrizon is USD 8.77M

What is the 1 year trading range for Polyrizon share price?

Polyrizon has traded in the range of US$ 0.77 to US$ 4.80 during the past year

What is the PE ratio of Polyrizon?

The price to earnings ratio of Polyrizon is -14.62

What is the reporting currency for Polyrizon?

Polyrizon reports financial results in USD

What is the latest annual profit for Polyrizon?

The latest annual profit of Polyrizon is USD -600k

What is the registered address of Polyrizon?

The registered address for Polyrizon is 5 HA-TIDHAR STREET, RA'ANANA, CENTER, 4366507

What is the Polyrizon website address?

The website address for Polyrizon is www.polyrizon-biotech.com

Which industry sector does Polyrizon operate in?

Polyrizon operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AEIAlset Inc	US$ 2.65 (159.80%)	6.6M
CMCTCreative Media and Community Trust Corporation	US$ 0.4807 (113.64%)	18.15M
CGBSCrown LNG Holdings Ltd	US$ 0.648 (61.96%)	2.31M
DMRCDigimarc Corporation	US$ 58.40 (55.94%)	1.21k
ORISOriental Rise Holdings Ltd	US$ 2.25 (47.06%)	1.75M
BDMDBaird Medical Investment Holdings Ltd	US$ 4.61 (-39.34%)	105.44k
AIPArteris Inc	US$ 8.01 (-21.39%)	49
BFINBankFinancial Corporation	US$ 10.01 (-21.15%)	3
CISOCISO Global Inc	US$ 2.80 (-19.31%)	3.34k
PRAAPRA Group Inc	US$ 17.02 (-18.53%)	3
CMCTCreative Media and Community Trust Corporation	US$ 0.4807 (113.64%)	18.15M
SVMHSRIVARU Holding Ltd	US$ 0.048 (14.01%)	15.35M
AEIAlset Inc	US$ 2.65 (159.80%)	6.6M
XTIAXTI Aerospace Inc	US$ 0.0419 (-2.56%)	4.09M
EYENEyenovia Inc	US$ 0.1499 (2.67%)	3.5M